Marc M. Loriaux, M.D., PhD.

Head Shot of Marc Loriaux
click here


Marc Loriaux, M.D., Ph.D. joined the Department of Pathology and Medicine in July, 2003 after completing a fellowship in Hematopathology at OHSU. He will help to staff the diagnostic hematopathology service and continue his research in Dr. Brian Druker’s laboratory studying tyrosine kinases as possible therapeutic targets in the treatment of hematologic malignancies.

Selected Publications

"A potential therapeutic strategy for chronic lymphocytic leukemia by combining idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor," Oncotarget (Vol: 5, Issue: 4, Page 908-915) - 2014

"BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein," Blood (Vol: 124, Issue: 22, Page 3260-3273) - 2014

"A case study of personalized therapy for osteosarcoma," Pediatric Blood and Cancer (Vol: 60, Issue: 8, Page 1313-1319) - 2013

"Comparison of methods to identify aberrant expression patterns in individual patients: Augmenting our toolkit for precision medicine," Genome Medicine (Vol: 5, Issue: 11, ) - 2013

"CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway," Leukemia (Vol: 27, Issue: 10, Page 2094-2096) - 2013


For Healthcare Professionals


  Email Marc Loriaux

503 494-8311

Memberships & Associations